KEYMED BIO-B(02162),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02162 KEYMED BIO-B

Trading 12-24 10:33:11

54.900

+0.000

0.00%

High55.550	Low53.000	Vol355.50K
Open53.000	D1 Closing54.900	Amplitude4.64%
Mkt Cap16.42B	Tradable Cap16.42B	Total Shares299.00M
T/O19.48M	T/O Rate0.12%	Tradable Shares299.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02162","market":"HK","secType":"STK","nameCN":"KEYMED BIO-B","latestPrice":54.9,"timestamp":1766543557262,"preClose":54.9,"halted":0,"volume":355500,"delay":0,"floatShares":299000000,"shares":299000000,"eps":-2.179299273808876,"marketStatus":"Trading","change":0,"latestTime":"12-24 10:33:11","open":53,"high":55.55,"low":53,"amount":19482846,"amplitude":0.046448,"askPrice":54.9,"askSize":7000,"bidPrice":54.65,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-1.0827448947409348,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766549400000},"marketStatusCode":2,"adr":0,"listingDate":1625673600000,"exchange":"SEHK","adjPreClose":54.9,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":1.504594,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02162","defaultTab":"news","newsList":[{"id":"1176519224","title":"HK Stock Movement | KEYMED BIO-B (02162) Opens Over 4% Higher as Sprifermin Injection Included in National Reimbursement Drug List","url":"https://stock-news.laohu8.com/highlight/detail?id=1176519224","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176519224?lang=en_us&edition=fundamental","pubTime":"2025-12-08 09:30","pubTimestamp":1765157433,"startTime":"0","endTime":"0","summary":"KEYMED BIO-B (02162) opened over 4% higher, rising 4.23% to HK$61.6 by the time of writing, with a turnover of HK$1.3244 million. On December 7, KEYMED BIO announced that its self-developed Class 1...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1587","BK1161","02162","BK1574"],"gpt_icon":0},{"id":"1199403427","title":"Keymed Biosciences Inc. (02162) Reports Steady Share Capital for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1199403427","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199403427?lang=en_us&edition=fundamental","pubTime":"2025-12-01 18:21","pubTimestamp":1764584466,"startTime":"0","endTime":"0","summary":"Keymed Biosciences Inc. (02162) released its monthly return on movements in securities for the period ended 30 November 2025. According to the announcement, the company’s authorized share capital...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162"],"gpt_icon":0},{"id":"1132878901","title":"HK Stock Movement | KEYMED BIO-B (02162) Rises Over 4% as Institutions Bullish on CM512's Global Value; Spesolimab Sales Expected to Accelerate Next Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1132878901","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132878901?lang=en_us&edition=fundamental","pubTime":"2025-11-25 11:32","pubTimestamp":1764041537,"startTime":"0","endTime":"0","summary":"KEYMED BIO-B (02162) surged over 4%, reaching HK$59.95 by the time of writing, with a trading volume of HK$31.28 million. The company recently announced that its self-developed CM512, the world's...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","02162","BK1161","BK1587"],"gpt_icon":0},{"id":"1171499670","title":"China Post Securities: Rapid Clinical Progress in Autoimmune Bispecific Antibodies, Sustained Trading and R&D Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1171499670","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171499670?lang=en_us&edition=fundamental","pubTime":"2025-11-18 11:22","pubTimestamp":1763436142,"startTime":"0","endTime":"0","summary":"China Post Securities released a research report stating that bispecific antibodies (BsAbs) in the autoimmune field have the potential to reshape the current treatment landscape, particularly in...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","BK1574","161027","BK1587","02162"],"gpt_icon":0},{"id":"1181014719","title":"HK Stock Connect Shareholding Changes | November 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1181014719","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181014719?lang=en_us&edition=fundamental","pubTime":"2025-11-12 08:38","pubTimestamp":1762907908,"startTime":"0","endTime":"0","summary":"As of November 11, 2025, data shows that HAO TIAN INTL (01341), REPT BATTERO (00666), and CTG DUTY-FREE (01880) recorded the largest increases in Stock Connect shareholding ratios, rising by 1.72%,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02050","HK0000252160.HKD","BK1191","03800","BK1522","01282","02382","BK1241","BK1590","06869","00525","BK1530","02013","BK1583","BK1589","MCHmain","BK1607","01071","LU0320764599.SGD","06955","00095","BK1202","LU0588546209.SGD","LU1720050803.USD","BK1555","BK1500","01341","01877","BK1170","LU0348825331.USD","03347","BK1587","BK1138","03866","BK1205","LU1211504680.USD","00902","00763","BK1511","01709","BK1606","LU2488822045.USD","02465","02727","02865","BK1504","02402","06682","09885","02068","BK1518","BK1183","BK1529","00666","IE00BZ08YT58.USD","BK1516","LU0348735423.USD","IE00BZ08YR35.GBP","BK1515","02631","BK1235","00874","02587","LU0326950275.SGD","BK1163","LU2328871848.SGD","BK1228","BK1588","LU0417516738.SGD","BK1129","SG9999003461.SGD","SG9999014674.SGD","01773","02648","BK1237","BK1523","LU2543165471.USD","BK1225","BK1240","BK1144","BK1554","02162","BK1125","BK1567","BK1148","02208","BK1513","BK1582","BK1503","09696","BK1505","BK1610","BK1161","02562","01880","01347","BK1147","BK1166","HK0000252152.HKD","HK0000500386.USD","LU0417516902.SGD","00189","03931","00568","SG9999006597.SGD","BK1608","03759","BK1546","BK1614","BK1526","LU1831875114.USD","01072","02255","02828","06865","BK1574","BK1169","BK1594","BK1613","00119","LU0052750758.USD","03678","09606","LU0708995583.HKD","06680","LU1983299162.USD","BK1576","LU1969619763.USD","09688","00956","01053","02837","09995","BK1109","BK1197","BK1568","BK1560","IE00B29SXG58.USD","BK1116","BK1564","BK1506","00968","BK1219","BK1171","BK1149","BK1558","BK1224","06616","IE00BZ08YS42.EUR","LU1794554557.SGD","06613","BK1110","00187","BK1236","BK1521","BK1596","LU0307460666.USD","BK1141","BK1556","IE0034224299.USD","02533"],"gpt_icon":1},{"id":"2581009628","title":"Why Is Keymed Biosciences (SEHK:2162) Drawing Big-Name Support After Stapokibart’s Approval in China?","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009628","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581009628?lang=en_us&edition=fundamental","pubTime":"2025-11-06 14:34","pubTimestamp":1762410883,"startTime":"0","endTime":"0","summary":"Goldman Sachs recently initiated coverage on Keymed Biosciences, highlighting the approval of its first commercial product, stapokibart, in China for atopic dermatitis and chronic rhinosinusitis, while expressing confidence in the pipeline asset CM512 for asthma and COPD.\nThis development underscores the growing recognition of Keymed's product pipeline and the confidence major institutions are placing in the company's future prospects.\nWe'll explore how optimism for Keymed's pipeline,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/why-is-keymed-biosciences-sehk2162-drawing-big-name-support","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/why-is-keymed-biosciences-sehk2162-drawing-big-name-support","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0106831901.USD","BK1574","BK4516","IE0034235188.USD","BK4550","LU2471134796.USD","IE00B19Z3B42.SGD","LU0251131958.USD","02162","IE00BFXG1179.USD","LU1894683348.USD","LU2237443622.USD","BK4552","LU2237443549.SGD","LU1868836914.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0048573561.USD","LU1791807156.HKD","LU1868836757.USD","LU1868837300.USD","LU2237443895.HKD","LU2750360641.GBP","IE0004086264.USD","BK4588","BK4504","LU2265009873.SGD","BK4533","LU2237443465.HKD","LU2237443978.SGD","LU2237438978.USD","LU2471134952.CNY","LU0345770993.USD","LU0251142724.SGD","IE0004091025.USD","BK4585","LU2750360997.AUD","BK1587","LU0096364046.USD","BK4127","LU1894683264.USD","LU0742534661.SGD","BK1161","LU0061475181.USD","LU2471134879.HKD","LU1804176565.USD","IE00BSNM7G36.USD","BK1583","LU1668664300.SGD","LU1868837136.USD"],"gpt_icon":0},{"id":"1105079913","title":"HK Stock Movement | KEYMED BIO-B (02162) Rises Over 3% Against Market Trend as CM512 Phase I Trial for Atopic Dermatitis Meets All Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=1105079913","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105079913?lang=en_us&edition=fundamental","pubTime":"2025-11-05 10:08","pubTimestamp":1762308495,"startTime":"0","endTime":"0","summary":"KEYMED BIO-B (02162) surged over 3% against the broader market trend, reaching HK$64.25 with a trading volume of HK$49.02 million by press time. The company announced on November 4 that its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","BK1583","BK1587","BK1574","TSLP","BK1161"],"gpt_icon":0},{"id":"1147559712","title":"HK Stock Movement | KEYMED BIO-B (02162) Surges Over 7% as Goldman Sachs Highlights Stapokibart's Potential to Establish Valuation Foundation","url":"https://stock-news.laohu8.com/highlight/detail?id=1147559712","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147559712?lang=en_us&edition=fundamental","pubTime":"2025-11-03 15:00","pubTimestamp":1762153237,"startTime":"0","endTime":"0","summary":"KEYMED BIO-B (02162) rose more than 7%, reaching HK$64.55 by the time of writing, with a trading volume of HK$281 million. Goldman Sachs issued a research report maintaining a \"Buy\" rating on KEYMED...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836914.USD","LU0251142724.SGD","LU2471134523.USD","BK1161","BK4552","LU2471134952.CNY","LU0345770308.USD","IE0004091025.USD","IE00BFXG1179.USD","LU2265009873.SGD","LU1894683264.USD","02162","BK4533","IE0004086264.USD","LU0061475181.USD","LU0742534661.SGD","BK4127","BK4516","IE0002270589.USD","IE0034235188.USD","LU0106831901.USD","LU2237443622.USD","LU2750360997.AUD","LU1894683348.USD","IE00B19Z3B42.SGD","LU1791807156.HKD","LU0345770993.USD","LU1868837300.USD","LU2237443895.HKD","LU1804176565.USD","LU2237443549.SGD","LU2471134796.USD","BK4550","BK1583","IE00B19Z3581.USD","LU2237438978.USD","LU2750360641.GBP","BK1587","BK4585","IE00BSNM7G36.USD","LU2237443465.HKD","GS","LU0251131958.USD","BK1574","LU0048573561.USD","BK4504","LU1668664300.SGD","LU2471134879.HKD","LU1868836591.USD","LU2237443382.USD","LU2237443978.SGD","BK4588","LU1868837136.USD","LU1868836757.USD","LU0096364046.USD"],"gpt_icon":0},{"id":"1102327383","title":"Southbound Capital Flow Statistics (T+2) | November 3","url":"https://stock-news.laohu8.com/highlight/detail?id=1102327383","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102327383?lang=en_us&edition=fundamental","pubTime":"2025-11-03 07:32","pubTimestamp":1762126364,"startTime":"0","endTime":"0","summary":"On October 28, HUA HONG SEMI (01347), POP MART (09992), and TSINGTAO BREW (00168) topped the market in terms of net southbound capital inflows, recording inflows of HK$388 million, HK$320 million,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1251922891.USD","IE0003851619.USD","BK1589","BK1179","LU0348814723.USD","LU0577902298.EUR","LU0132412106.USD","LU0214875030.USD","BK1129","BK1185","LU0819121731.USD","LU1044874839.SGD","LU0169518387.USD","LU1642822792.SGD","LU2237443549.SGD","BK1586","LU1804176565.USD","SG9999001093.SGD","LU0823413587.USD","01171","LU0359202008.SGD","SG9999018857.SGD","LU0449515922.USD","01071","LU2148510915.USD","06616","LU0762540952.USD","BK1095","02628","BK1227","LU2317271919.USD","IE00B031J352.USD","LU0266512473.USD","BK1591","BK1166","LU1115378108.SGD","SG9999001069.SGD","LU2543165471.USD","BK1507","IE00BGHQDM52.EUR","LU2251237306.USD","BK1198","LU0630378692.HKD","PAImain","ANPDY","LU0211331839.USD","LU1226288253.USD","LU1961090484.USD","SG9999015952.SGD","LU0348816934.USD","LU0865486749.SGD","LU0345780281.USD","LU0072913022.USD","LU0577902538.SGD","BK1189","BK1125","SG9999014674.SGD","IE00B0JY6N72.USD","LU0054237671.USD","LU1725190679.HKD","LU0149721374.USD","BK1504","BK1542","LU0469268626.HKD","LU1323998911.USD","LU0181495838.USD","BK1119","LU2177674079.SGD","BK1557","IE0008368304.USD","BK1517","LU1974910355.USD","SGXZ31699556.SGD","LU0608807946.USD","LU0572939691.SGD","LU0293314216.USD","LU0821914370.USD","LU2226246903.HKD","BK1516","LU0048388663.USD","LU0254981946.USD","LU1051769294.HKD","LU0878004406.USD","IE0003895053.USD","LU0228367735.SGD","LU2237443465.HKD","SG9999002463.SGD","LU1522347837.USD","LU1226287792.SGD","IE00B0169L03.USD","LU0588546209.SGD","BK1604","LU0499858438.USD","LU2097828557.USD","IE0032834883.USD","LU0502904849.HKD","LU0541501648.USD","82020","IE00BF5LJ272.USD","LU0823041008.USD","LU0320764243.SGD","LU0188438112.USD","HK0000306701.USD","LU0828238088.HKD","LU1981816686.USD","LU0856984785.SGD","BK1597","LU2153592121.USD","LU2449936058.SGD","LU0683595622.HKD","LU0431992006.USD","IE00BMPRXR70.SGD","03396","LU0348783662.USD","LU0106959298.USD","LU2279701549.SGD","LU0067412154.USD","BK1161","LU0784639295.USD","LU0828237510.HKD","LU2237443978.SGD","LU0084288322.USD","LU0096374516.USD","02020","BK1096","BHKLY","BK1186","LU0149534421.HKD","LU1813983027.USD","BK1588","LU0531970944.HKD","LU0441854154.USD","LU0589944569.HKD","BK1587","89988","SG9999000327.SGD","IE00B8L5B284.USD","LU1831875114.USD","LU1044876610.USD","BK1592","SG9999014880.SGD","SG9999014898.SGD","01276","BK1180","LU0672654166.SGD","LU1993786604.SGD","LU2348774022.SGD","BK1168","LU2152927971.USD","BK1190","LU0831093199.SGD","LU0651946864.USD","IE0032431581.USD","LU0314109678.HKD","LU1720050803.USD","SG9999000459.SGD","LU0320764755.SGD","HK0000252152.HKD","LU0823040885.USD","LU0315178854.USD","LU0128522157.USD","BK1530","IE00B8HQ1Z84.USD","GB00BDT5M118.USD","LU0173614495.USD","LU1048484197.HKD","LU0955669360.SGD","LU2251237488.HKD","BK1191","LU2399975544.HKD","LU0708995153.HKD","LU0823038988.USD","LU0985320562.USD","LU0345769631.USD","LU1568876335.HKD","LU0143863198.USD","LU2362541513.USD","LU1196710351.USD","IE0008368742.USD","IE00B97KM107.HKD","IE00BMPRXN33.USD","PNGAY","BK1531","IE00B0169N27.USD","LU1868837565.USD","BK1538","LU1720051017.SGD","LU0048597586.USD","IE00BZ08YT58.USD","LU0762541174.USD","LU0577902371.SGD","LU0289960550.SGD","00811","LU1769817179.HKD","LU0979878070.USD","LU0642271901.SGD","02899","BK1609","IE0008368411.USD","LU0047713382.USD","LU0516422952.EUR","BK1501","01347","LU0264606111.USD","LU1481107354.HKD","IE0009570106.USD","LU0737861699.HKD","BK1594","LU0029875118.USD","IE00B29SXG58.USD","LU1226288097.SGD","LU0918141887.USD","LU0955648018.USD","LU1568876251.USD","LU0307460666.USD","01024","BK1539","LU1634259557.SGD","02318","HK0000320264.USD","LU1720051108.HKD","03993","LU0266512127.USD","LU2106854487.HKD","LU0164880469.USD","LU0061477393.USD","LU0106259558.USD","LU0164872284.USD","LU0348766576.USD","82388","LU1880398554.USD","BK1550","LU0117841782.USD","LU0345780521.USD","LU0516422366.SGD","BK1582","SG9999014906.USD","LU0456842615.SGD","SG9999014914.USD","LU0348723411.USD","LU0823039010.USD","LU0417516738.SGD","LU0229945570.USD","LU0348825331.USD","LU0898667661.SGD","LU0509642566.USD","LU1064131003.USD","SG9999007991.SGD","LU0029874905.USD","LU1769817096.USD","LU0417516902.SGD","LU0163747925.USD","00941","LU1655091459.SGD","02015","LU0449509016.USD","LU0456827905.SGD","LU0607220059.USD","BK1615","LU0345776255.USD","LU1868838027.USD","LU0611395673.USD","BK1519","LU0823413660.USD","LU0164865239.USD","LU0456846285.SGD","LU0052750758.USD","LU2265009873.SGD","LU0634319403.HKD","LU1794554557.SGD","IE00B3M56506.USD","LU0572944931.SGD","LU1226287875.USD","IE00B067MR52.USD","SGXZ86797644.SGD","LU1328615791.USD","LU0791591158.USD","LU0231483743.USD","BK1575","HBBD.SI","SG9999012744.USD","LU2247934214.USD","LU0648000940.SGD","LU1188198961.HKD","LU1196710864.SGD","SG9999000418.SGD","LU1303224171.USD","02666","LU0791590937.USD","LU0873338254.USD","SG9999001051.SGD","LU0235996351.USD","LU0072462343.USD","LU1242518857.USD","BK1505","SG9999013353.USD","LU0417516571.SGD","IE00B031HW06.USD","LU0588545730.USD","LU0593848301.USD","LU1880398471.USD","SG9999012728.SGD","SGXZ90724238.SGD","09992","LU0823397103.USD","LU1023057109.AUD","LU0251143458.SGD","SG9999001846.SGD","LU0261947096.USD","LU2257852520.SGD","00751","BK1163","LU0192582467.USD","LU2237443382.USD","LU0143863784.USD","BK1502","IE0031814852.USD","IE00BVYPNP33.GBP","BK1607","LU0348735423.USD","LU1211504680.USD","LU0823397285.USD","00995","LU0823426480.USD","LU0048580855.USD","LU1629966141.USD","BK1553","BK1614","BK1178","LU1810669033.SGD","SGXZ62798434.SGD","IE00BQXX3C00.GBP","LU1282649067.USD","LU0633140727.USD","02162","IE00BGV7N243.SGD","LU0882747503.HKD","BK1183","LU1808992512.USD","IE00BPRC5H50.USD","LU1328277881.USD","BK1500","LU1226287529.USD","LU0348784397.USD","LU1051768304.USD","LU1785774172.SGD","LU0261950470.USD","SG9999015978.USD","LU0543330566.HKD","BK1219","LU0868486357.SGD","HPAD.SI","LU1770034418.SGD","HK0000500386.USD","LU2097828631.EUR","LU1044875133.USD","LU1196710195.USD","03145","LU1226288170.HKD","HK0000252160.HKD","LU0396098781.USD","LU1008478684.HKD","LU0594300419.USD","SG9999006514.SGD","BK1506","LU0463099449.HKD","LU0477156797.USD","LU2008162690.USD","BK1184","BK1510","LU0049112450.USD","LU0823426308.USD","LU0320764599.SGD","BK1536","BK1578","09868","LU0516423091.SGD","80883","LU0165289439.USD","601318","LU0455707207.USD","LU0128522744.USD","LU0211977185.USD","LU1548497426.USD","HK0000320223.HKD","BK1130","LU1102505929.USD","SG9999003461.SGD","LU0384037296.USD","01117","LU2237443622.USD","LU1880383440.USD","SGXZ51526630.SGD","LU1102505762.USD","BK1560","BK1567","LU0370786039.SGD","LU0287142896.SGD","LU0051755006.USD","LU2087589342.USD","LU0831103253.SGD","LU0210527791.USD","LU1504937902.USD","LU0197773160.USD","LU1634259391.SGD","IE0003795394.USD","LU0197773673.USD","LU0577902454.USD","LU0700851271.USD","00956","82318","LU0456854461.SGD","LU1497733557.USD","LU0348805143.USD","LU0269904917.USD","LU2133065610.SGD","BK1521","BK1512","LU1733274473.HKD","LU0203347892.USD","LU1439102457.SGD","LU1675838814.USD","00700","BK1212","SG9999002562.SGD","LU0650527681.SGD","LU0605514214.HKD","BK1584","LU1951186391.HKD","LU0588545490.SGD","LU0878005551.USD","LU0633140560.USD","LU0540923850.HKD","LU1282648689.USD","LU0516422440.USD","LU2778985437.USD","IE0008369823.USD","LU0608807433.USD","BK1610","81024","LU2023250504.SGD","LU0244354667.USD","BK1583","LU2125910849.SGD","01112","02648","LU0762542818.HKD","LU2097828474.EUR","BK1249","LU0130103400.USD","LU0531971595.HKD","LU0011963245.USD","LU1105468828.SGD","LU1734074674.USD","LU1883866441.USD","SG9999018865.SGD","00548","LU2488822045.USD","LU0210533765.USD","LU0048575426.USD","03968","LU0871576103.HKD","BK1503","LU1224709979.USD","03933","LU2362540622.SGD","LU0196878994.USD","BK1590","LU1064130708.USD","LU1814569148.SGD","LU0326950275.SGD","BK1224","SG9999001689.USD","BK1558","SG9999002950.SGD","00168","LU2125910500.SGD","LU1048588211.SGD","BK1574","LU0819123356.HKD","03143","LU2293587155.HKD","LU1917777945.USD","LU0651947912.USD","LU0259732245.USD","LU0175139822.USD","LU0345769128.USD","LU1242518931.SGD","LU0862451753.SGD","LU2051468812.USD","BK1608","LU0328353924.USD","LU0359201885.HKD","00883","IE00BZ08YR35.GBP","LU0414403682.SGD","LU0862451837.USD","LU1366334578.USD","IE0034224299.USD","LU0488056044.USD","LU0630378429.USD","LU2362541273.HKD","SG9999001903.USD","BK1097","IE00B031HY20.USD","LU0043850808.USD","LU2498475776.HKD","BK1142","IE00B543WZ88.USD","LU2039709279.SGD","LU0107464264.USD","LU0648948544.HKD","LU0261950983.USD","BK1104","LU0315179316.USD","SG9999017495.SGD","LU1366334651.USD","LU1515016050.SGD","LU2357305700.SGD","LU0326948709.USD","IE00BVYPNQ40.USD","LU0594300179.USD","01478","LU0541502299.USD","LU0130518102.USD","LU0572940350.SGD","LU1282649141.HKD","LU1497734951.SGD","LU0117844026.USD","LU0106252389.USD","LU0588545904.SGD","LU0228659784.USD","LU1807302812.USD","SG9999015986.USD","SG9999004220.SGD","LU1960683339.HKD","09988","LU0737861772.HKD","LU1880383366.USD","SG9999012736.USD","LU0329678170.USD","IE00BYV24P56.USD","BK1181","BK1238","LU0640798160.USD","LU0501845795.SGD","LU1868837722.USD","IE00BQXX3D17.EUR","LU2237443895.HKD","LU0054450605.USD","LU0359201612.USD","LU1046422090.SGD","LU0203345920.USD","LU0348788117.USD","LU1770036033.HKD","BK1231","LU1439103000.SGD","SGXZ99366536.SGD","LU1497733631.SGD","SG9999015945.SGD","LU0738912210.USD","LU0210526637.USD","LU2476274720.SGD","SG9999001226.SGD","BK1544","LU0345775950.USD","03899","LU0561508036.HKD","LU0880133367.SGD","LU1224444064.USD","02388","LU1152091168.USD","LU0577902611.USD","IE00B5MMRT66.SGD","LU2045819591.USD","LU0348767384.USD","LU0140636845.USD","LU2097829019.USD","LU1282651121.HKD","LU1733274390.USD","LU0543330483.HKD","LU0890818403.SGD","LU0251144936.SGD","LU2097828805.USD","LU0049853897.USD","KSTmain","HTCD.SI","03033","LU0348783233.USD","LU0797268264.HKD","BK1528","LU1316542783.SGD","BK1526","LU0127658192.USD","02192","LU0886674414.USD","LU0918141705.HKD","LU3063872942.SGD","02669","HK0000306685.HKD","BK1522","LU0080751232.USD","LU1282649810.SGD","LU2242644610.SGD","BK1572","LU2097828714.EUR","LU2462611646.USD","LU0327786744.USD","LU1282651048.USD","LU0499858602.USD","BK1618","LU2476274308.USD","BK1193","LU0516423174.USD","SG9999012710.SGD","LU0039217434.USD","SG9999002828.SGD","LU0348827113.USD","LU1152091754.HKD","SGXZ81514606.USD","LU0972618739.USD","IE00BMCWC346.EUR","LU1048596156.SGD","LU0675040207.SGD","LU0329678337.USD","LU1130305938.SGD","LU0708995583.HKD","IE00BQXX3F31.USD","BK1237","LU0828237940.HKD","LU1688375341.USD","LU1201861165.SGD","00777","LU1719994722.HKD","SG9999006597.SGD","LU0786609619.USD","LU0955623706.USD","IE00BZ08YS42.EUR","LU1235295612.USD","LU1956131251.USD","BK1152"],"gpt_icon":1},{"id":"1112926226","title":"HK Stock Connect Shareholding Changes as of October 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1112926226","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112926226?lang=en_us&edition=fundamental","pubTime":"2025-10-30 08:38","pubTimestamp":1761784715,"startTime":"0","endTime":"0","summary":"As of October 28, 2025, data shows that **SANHUA (02050)**, **CHIFENG GOLD (06693)**, and **QUNABOX GROUP (00917)** recorded the largest increases in Stock Connect shareholding ratios, rising by...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02050","BK1614","BK1180","LU0463099449.HKD","01787","BK1501","SG9999006597.SGD","LU0572940350.SGD","LU1960683339.HKD","HK0000252160.HKD","BK1109","BK1523","BK1591","02465","03347","LU1226287875.USD","03069","LU1152091754.HKD","01093","BK1516","HK0000500386.USD","01053","LU0181495838.USD","BK1574","LU0164880469.USD","09696","BK1171","BK1562","BK1613","LU1993786604.SGD","02837","00189","06693","BK1206","BK1183","LU1831875114.USD","LU2213484517.USD","BK1161","02648","BK1129","LU0149721374.USD","BK1148","03677","01635","BK1505","LU0405327148.USD","02828","06936","BK1258","HK0000252152.HKD","LU1969619763.USD","IE00BZ08YS42.EUR","06682","BK1140","LU2488822045.USD","00564","LU1951186391.HKD","BK1558","BK1173","00358","02600","BK1550","02162","BK1138","BK1578","IE00BZ08YT58.USD","01057","BK1564","IE00B031HY20.USD","BK1544","03678","BK1104","BK1584","BK1116","BK1610","BK1163","00895","09878","LU0264606111.USD","BK1237","BK1184","BK1229","BK1241","LU0572944931.SGD","LU1226288253.USD","BK1221","09660","LU1813983027.USD","LU1226287529.USD","IE00BGV7N243.SGD","IE00BZ08YR35.GBP","BK1191","01065","01709","01119","02582","03993","BK1576","BK1522","02208","LU2039709279.SGD","LU1226288170.HKD","00168","09880","01528","LU1152091168.USD","BK1592","BK1225","01033","LU0067412154.USD","BK1124","LU0315179316.USD","02068","01336","LU0880133367.SGD","BK1568","01341","LU0140636845.USD","LU2328871848.SGD","BK1141","02533","SG9999004311.SGD","03369","BK1531","02169","LU0572939691.SGD","BK1144","00917","BK1190","BK1198","BK1208","LU0501845795.SGD","01385","02367","BK1546","BK1207","MCHmain","BK1587","BK1506","LU0828237940.HKD","LU1188198961.HKD","BK1510","LU0244354667.USD","BK1526","LU0405327494.USD","IE00B5MMRT66.SGD","BK1147","02255","01072","LU0314109678.HKD","06869","LU1008478684.HKD","LU0307460666.USD","09995","BK1202","SG9999004220.SGD","LU1328277881.USD","BK1110","01729","BK1535","BK1594","LU0072913022.USD","LU0327786744.USD","LU1807302812.USD","BK1149","BK1175","02402","09606","02945","BK1604","BK1521","BK1515","BK1154","SG9999014674.SGD","LU1481107354.HKD","IE0008368742.USD","IE00B543WZ88.USD","00412","06616","BK1205","BK1240","IE0008369823.USD","06680","LU2543165471.USD","BK1151","BK1137","BK1511","BK1552","BK1513","BK1236","00588","BK1537","LU0588546209.SGD","LU0326950275.SGD","LU1226287792.SGD","BK1583"],"gpt_icon":1},{"id":"1120022384","title":"Hong Kong Stocks Movement | Pharmaceutical Stocks Continue Multi-Day Decline Amid Short-Term External Environment Changes, Institutions Remain Optimistic About Long-Term Industry Development Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=1120022384","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120022384?lang=en_us&edition=fundamental","pubTime":"2025-10-14 14:30","pubTimestamp":1760423428,"startTime":"0","endTime":"0","summary":"Pharmaceutical stocks have continued their sluggish performance over consecutive days, with declines expanding further in the afternoon session. As of press time, VIVA BIOTECH (01873) dropped 7.53%...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1515","BK1587","01873","BK1583","159938","BK1141","09939","01672","BK1576","BK1574","02162","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"1118647681","title":"Hong Kong Stock Movement | KEYMED BIO-B (02162) Surges Over 5% Intraday as First Dual-Antibody Drug CM336 Initiates Phase III Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1118647681","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118647681?lang=en_us&edition=fundamental","pubTime":"2025-09-22 10:22","pubTimestamp":1758507745,"startTime":"0","endTime":"0","summary":"KEYMED BIO-B (02162) surged over 5% during intraday trading. As of press time, the stock was up 4.58% to HK$75.4, with turnover reaching HK$87.53 million. On the news front, according to global...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","III","BK1574","BK1583","07226","BK4134","HSCEI","YANG","02162","BK4614","BK1587"],"gpt_icon":1},{"id":"2567389168","title":"Is There Still Potential in Keymed Biosciences After Shares Double in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2567389168","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567389168?lang=en_us&edition=fundamental","pubTime":"2025-09-14 23:35","pubTimestamp":1757864150,"startTime":"0","endTime":"0","summary":"Thinking about what to do with Keymed Biosciences stock? You are not alone. Investors have had to contend with some wild swings lately, and figuring out the right move feels more important than ever. After notching a remarkable 151.1% gain so far this year, Keymed’s shares more than doubled, leaving even longtime holders blinking at their account balances. Over the past year, the stock is up 91.1% and still riding close to multi-year highs. There was a 3.2% dip just last week and a slight...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/is-there-still-potential-in-keymed-biosciences-after-shares","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/is-there-still-potential-in-keymed-biosciences-after-shares","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","02162","DCF","BK4211","BK1587","BK1161","FCF","BK1583"],"gpt_icon":0},{"id":"1189676359","title":"Hong Kong Stocks Alert | KEYMED BIO-B (02162) Surges Over 10% in Morning Session on Strong H1 Subcilizumab Commercial Performance and Robust Competitive Position in Atopic Dermatitis Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1189676359","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189676359?lang=en_us&edition=fundamental","pubTime":"2025-09-05 11:56","pubTimestamp":1757044578,"startTime":"0","endTime":"0","summary":"KEYMED BIO-B (02162) surged over 10% in morning trading. As of press time, the stock was up 10.07% at HK$75.4, with turnover reaching HK$171 million. On the news front, KEYMED BIO-B recently released...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","AD","BK1587","BK4132","02162","BK1161"],"gpt_icon":0},{"id":"1140608162","title":"Bank of Communications International Raises KEYMED BIO-B Target Price to HK$78 as Core Products Accelerate Market Penetration in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=1140608162","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140608162?lang=en_us&edition=fundamental","pubTime":"2025-08-29 17:41","pubTimestamp":1756460470,"startTime":"0","endTime":"0","summary":"Bank of Communications International issued a research report stating that based on KEYMED BIO-B's (02162) first-half performance and pipeline development progress this year, the firm has adjusted...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","02162","BK1587","BK1583"],"gpt_icon":0},{"id":"2562133794","title":"KeyMed Biosciences (02162.HK) Reports Strong Interim 2025 Results With Accelerated Commercialization and Robust R&D Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2562133794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562133794?lang=en_us&edition=fundamental","pubTime":"2025-08-27 14:02","pubTimestamp":1756274558,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nTUAJ3VPW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1587","BK1161","02162","BK1583"],"gpt_icon":0},{"id":"1169407745","title":"HK Movers | Biotech Stocks Decline, Clover Biopharmaceuticals Drops Over 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169407745","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169407745?lang=en_us&edition=fundamental","pubTime":"2025-08-27 13:36","pubTimestamp":1756272979,"startTime":"0","endTime":"0","summary":"Biotechnology stocks fell in Hong Kong in the afternoon, with Clover Biopharmaceuticals dropping more than 14%. Canbridge Pharmaceuticals fell nearly 8%, while Genor Biopharma dropped nearly 7%. Keymed Biosciences fell 6%, JW (Cayman) Therapeutics fell 4%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1c8d330ce0386dff71942fca29a770ca","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02197","01228","02126","02162","06998"],"gpt_icon":0},{"id":"1162997427","title":"Stock Track | KEYMED BIO-B Soars 5.09% as CICC Raises Target Price by 54.5% to HK$85.00","url":"https://stock-news.laohu8.com/highlight/detail?id=1162997427","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162997427?lang=en_us&edition=fundamental","pubTime":"2025-08-27 09:58","pubTimestamp":1756259936,"startTime":"0","endTime":"0","summary":"KEYMED BIO-B (02162) saw its stock price soar by 5.09% in Wednesday's trading session, following a bullish research report from CICC. The investment bank maintained its outperform rating on the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02162"],"gpt_icon":0},{"id":"1164388116","title":"CICC Maintains Outperform Rating on KEYMED BIO-B (02162), Raises Target Price to HK$85.00","url":"https://stock-news.laohu8.com/highlight/detail?id=1164388116","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164388116?lang=en_us&edition=fundamental","pubTime":"2025-08-27 09:56","pubTimestamp":1756259785,"startTime":"0","endTime":"0","summary":"CICC has released a research report stating that due to the recognition of upfront and milestone payments from the out-licensing of KEYMED BIO-B's (02162) CM313 and CM355, the firm has adjusted its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1587","BK1574","BK1161","02162"],"gpt_icon":0},{"id":"2562341527","title":"Keymed Biosciences Narrows Loss in H1; CFO Steps Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2562341527","media":"MT Newswires Live","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562341527?lang=en_us&edition=fundamental","pubTime":"2025-08-26 21:38","pubTimestamp":1756215501,"startTime":"0","endTime":"0","summary":"Keymed Biosciences  narrowed its attributable loss to 78.8 million yuan in the first half of 2025 from 336.7 million yuan a year prior, a Tuesday Hong Kong bourse filing said.Loss per share for the biopharmaceutical firm was 0.30 yuan, down from 1.29 yuan in the year-ago period.Revenue for the interim period increased 812% to 498.8 million yuan from 54.7 million yuan in the corresponding period of the last year.In separate news, Yanrong Zhang resigned as the firm's chief financial officer effective immediately to devote more time to other commitments. Zhang will now act as a consultant for the company.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02162"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0233},{"period":"1month","weight":-0.0249},{"period":"3month","weight":-0.2246},{"period":"6month","weight":0.139},{"period":"1year","weight":0.7237},{"period":"ytd","weight":0.7767}],"compareEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.022},{"period":"3month","weight":-0.0281},{"period":"6month","weight":0.0596},{"period":"1year","weight":0.2963},{"period":"ytd","weight":0.2849}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"KeyMed Biosciences Inc is a biotechnology company principally engaged in the in-house discovery and development of innovative biological therapies in the autoimmune and oncology therapeutic areas. The Company also focused on the research and development of pharmaceutical products. The Company's main products comprise CM310, CM326, CM313 and CM383, mainly used for treating various type II immunological diseases in adults, adolescents and children, including moderate-to-severe atopic dermatitis (AD), moderate-to-severe asthma, CRSwNP, AR and potentially COP. The Company has also established a fully integrated platform covering the key functions of biopharmaceutical development. The Company mainly conducts its businesses in the domestic market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.087989},{"month":2,"riseRate":0.75,"avgChangeRate":0.088362},{"month":3,"riseRate":0.25,"avgChangeRate":-0.018584},{"month":4,"riseRate":1,"avgChangeRate":0.037917},{"month":5,"riseRate":0.25,"avgChangeRate":-0.097555},{"month":6,"riseRate":1,"avgChangeRate":0.124436},{"month":7,"riseRate":0.5,"avgChangeRate":0.132155},{"month":8,"riseRate":0.6,"avgChangeRate":0.038036},{"month":9,"riseRate":0.8,"avgChangeRate":0.042936},{"month":10,"riseRate":0.4,"avgChangeRate":0.003137},{"month":11,"riseRate":0.6,"avgChangeRate":0.04569},{"month":12,"riseRate":0.2,"avgChangeRate":-0.140204}],"exchange":"SEHK","name":"KEYMED BIO-B","nameEN":"KEYMED BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"KEYMED BIO-B(02162),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest KEYMED BIO-B(02162) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"KEYMED BIO-B,02162,KEYMED BIO-B股票,KEYMED BIO-B股票老虎,KEYMED BIO-B股票老虎国际,KEYMED BIO-B行情,KEYMED BIO-B股票行情,KEYMED BIO-B股价,KEYMED BIO-B股市,KEYMED BIO-B股票价格,KEYMED BIO-B股票交易,KEYMED BIO-B股票购买,KEYMED BIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"KEYMED BIO-B(02162),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest KEYMED BIO-B(02162) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}